The association between the IRF5 genotype and SSc patients, especially those with anti-topo I-positive diffuse cutaneous SSc (dcSSc) with ILD, was first reported in French population by CGA [21] and was later replicated in independent studies [46]. This evidence concerns the gene IRF5 and interstitial lung disease.